DAWN supply chain intelligence for Day One Biopharmaceuticals Inc: verified suppliers, customers, debt relationships, acquisitions, and ownership data.
Servier Detroit Inc., a Delaware corporation and a wholly owned subsidiary of Parent, entered into an Agreement and Plan of Merger with Day One Biopharmaceuticals, Inc.
on March 6, 2026, Servier Pharmaceuticals LLC, a Delaware limited liability company, entered into an Agreement and Plan of Merger with Day One Biopharmaceuticals, Inc.
Servier S.A.S., a French société par actions simplifiée, solely as a guarantor, entered into an Agreement and Plan of Merger with Day One Biopharmaceuticals, Inc.
the Company provided written notice to Piper Sandler & Co. and JonesTrading Institutional Services LLC as sales agents of its election to terminate the Equity Distribution Agreement
the Company provided written notice to Piper Sandler & Co. and JonesTrading Institutional Services LLC as sales agents of its election to terminate the Equity Distribution Agreement
In addition, the Ipsen License Agreement provides that we will supply to Ipsen, and Ipsen will purchase from us, all required quantities of tovorafenib for all territories outside the United States i…
as well as our commercial products. We believe that this strategy allows us to maintain a more efficient infrastructure by eliminating the need for us to invest in our own manufacturing facilities, e…
as well as our commercial products. We believe that this strategy allows us to maintain a more efficient infrastructure by eliminating the need for us to invest in our own manufacturing facilities, e…
t the end of each reporting period. The adjustments are recorded in the same period the related revenue is recognized, resulting in a reduction of product revenue and the establishment of a current l…
tion. The Company identified two distinct performance obligations for licenses to intellectual property in the form of the exclusive license to commercialize tovorafenib outside the United States for…
on the financial condition and creditworthiness of customers and the Company considers economic factors and events or trends expected to affect future collections experience. Any allowance would redu…
Day One Biopharmaceuticals Inc Debt Obligations
Instrument
Description
Confidence
Evidence
DAWN-DEBT
Debt stack $2.8M
90%
Market cache reports total debt of $2.8M.
DAWN-DEBT-9023
Warrants outstanding: 20941000
90%
xbrl warrant detail from xbrl 2024-12-31.
Day One Biopharmaceuticals Inc Acquisitions
No acquisitions on recordNo completed or pending acquisitions found in our database for Day One Biopharmaceuticals Inc.
Day One Biopharmaceuticals Inc Ownership
Holder
Name
Confidence
Evidence
DAWN-OWNER-BLACKROCK-INC
BlackRock, Inc.
90%
13F overlay lists BlackRock, Inc. as top holder; 216 tracked holders.
Day One Biopharmaceuticals Inc Extended Supply Chain Network
